Naltrexone, serotonin receptor subtype antagonists, and carbohydrate intake in rats.
Functional interactions between serotonergic (5-HT) and opioid drugs have been observed with 5-HT3 receptor antagonism enhancing the inhibitory actions of naloxone and naltrexone in both food-deprived and glucoprivic rats; 5-HT2A/C receptor antagonism enhanced naltrexone's inhibition of insulin hyperphagia. The present study examined whether pretreatment with either general 5-HT (methysergide: 0.5-5 mg/kg), 5-HT2A/C (ritanserin: 0.25-2.5 mg/kg), or 5-HT3 (ICS 205930: 0.5-5 mg/kg) antagonists altered the pattern and magnitude of ad lib intake of simple (sucrose: 10%) or more complex (maltose dextrin: MD, 10%) carbohydrate solutions, or naltrexone's (0.25-2.5 mg/kg) inhibition of these forms of intake. Methysergide significantly increased the pattern and magnitude of sucrose intake at low (0.5-2.5 mg/kg) doses, and transiently delayed the pattern of MD intake at high (5 mg/kg) doses. Ritanserin significantly accelerated the pattern, but not the magnitude of sucrose intake at low (0.25-1.25 mg/kg) doses without affecting MD intake. ICS 205930 reduced the magnitude of sucrose intake at the highest (5 mg/kg) dose, and transiently reduced MD intake. Naltrexone dose dependently altered the pattern and magnitude of both sucrose and MD intake. Coadministration of ritanserin and naltrexone either eliminated or delayed the pattern of opioid antagonist inhibition of both sucrose and MD intake. Methysergide and ICS 205930 pretreatment produced minor changes in the pattern of naltrexone-induced inhibition. These data indicate that 5-HT receptor differentially modulate the pattern of carbohydrate intake, and indicate differential ingestive interactions between 5-HT and opioid antagonists under challenge and palatable conditions.
Islam
A K
AK
Department of Psychology, Queens College, City University of New York, Flushing 11367.
Dougherty
T
T
Koch
J E
JE
Bodnar
R J
RJ
D000818:Animals; D004040:Dietary Carbohydrates; D004435:Eating / Q000187:drug effects*; D005508:Food Deprivation / Q000502:physiology; D007211:Indoles / Q000494:pharmacology; D008297:Male; D008320:Maltose; D008784:Methysergide / Q000494:pharmacology; D009271:Naltrexone / Q000494:pharmacology*; D011134:Polysaccharides; D051381:Rats; D017207:Rats, Sprague-Dawley; D016713:Ritanserin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013395:Sucrose; D000077526:Tropisetron
D004040:Dietary Carbohydrates; D007211:Indoles; D011134:Polysaccharides; D012702:Serotonin Antagonists; D016713:Ritanserin; D013395:Sucrose; D009271:Naltrexone; D008320:Maltose; D000077526:Tropisetron; C008315:maltodextrin; D008784:Methysergide